Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Epidermal Growth Factor Receptor 2 (HER2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01038804
What this trial is testing

YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Astellas Pharma Inc 101
Testing effectiveness (Phase 2)Study completedNCT01722968
What this trial is testing

A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel

Who this might be right for
Breast Cancer
Theodoros Foukakis 33
Testing effectiveness (Phase 2)Looking for participantsNCT07220135
What this trial is testing

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center 100
Large-scale testing (Phase 3)Looking for participantsNCT05256225
What this trial is testing

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Who this might be right for
Endometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more
National Cancer Institute (NCI) 360
Early research (Phase 1)Study completedNCT02154776
What this trial is testing

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

Who this might be right for
Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 13
Testing effectiveness (Phase 2)WithdrawnNCT04220476
What this trial is testing

CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer

Who this might be right for
Breast Cancer
Weill Medical College of Cornell University
Not applicableStudy completedNCT01615068
What this trial is testing

An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Who this might be right for
Breast Cancer
Genentech, Inc. 1,007
Testing effectiveness (Phase 2)Looking for participantsNCT07285382
What this trial is testing

Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo 120
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Large-scale testing (Phase 3)UnknownNCT03085368
What this trial is testing

Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

Who this might be right for
HER2-positive Breast Cancer
Peking Union Medical College Hospital 482
Testing effectiveness (Phase 2)Ended earlyNCT04298918
What this trial is testing

A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Looking for participantsNCT06434597
What this trial is testing

A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.

Who this might be right for
Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
Shanghai Pharmaceuticals Holding Co., Ltd 60
Not applicableStudy completedNCT00911716
What this trial is testing

TC Avastin. ICORG 08-10, V6

Who this might be right for
Breast Cancer
Cancer Trials Ireland 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT06068985
What this trial is testing

Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Latin American Cooperative Oncology Group 63
Early research (Phase 1)UnknownNCT01304797
What this trial is testing

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Merrimack Pharmaceuticals 75
Large-scale testing (Phase 3)Looking for participantsNCT05891093
What this trial is testing

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

Who this might be right for
Breast Cancer
Fudan University 766
Large-scale testing (Phase 3)Study completedNCT03425656
What this trial is testing

Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
AryoGen Pharmed Co. 108
Early research (Phase 1)Active Not RecruitingNCT05143229
What this trial is testing

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center 18
Not applicableNot Yet RecruitingNCT07132502
What this trial is testing

Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 24
Testing effectiveness (Phase 2)Study completedNCT00741260
What this trial is testing

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 105
Next Page